@article {17376,
	title = {Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2},
	journal = {J Viral HepatJ Viral HepatJ Viral Hepat},
	volume = {22 Suppl 1},
	year = {2015},
	note = {Gane, EKershenobich, DSeguin-Devaux, CKristian, PAho, IDalgard, OShestakova, INymadawa, PBlach, SAcharya, SAnand, A CAndersson, M IArendt, VArkkila, PBaatarkhuu, OBarclay, KBen-Ari, ZBergin, CBessone, FBlokhina, NBrunton, C RChoudhuri, GChulanov, VCisneros, LCroes, E ADahgwahdorj, Y ADaruich, J RDashdorj, N RDavaadorj, Dde Knegt, R Jde Vree, MGadano, A CGower, EHalota, WHatzakis, AHenderson, CHoffmann, PHornell, JHoulihan, DHrusovsky, SJarcuska, PKostrzewska, KLeshno, MLurie, YMahomed, AMamonova, NMendez-Sanchez, NMossong, JNorris, SNurmukhametova, EOltman, MOyunbileg, JOyunsuren, TsPapatheodoridis, GPimenov, NPrins, MPuri, PRadke, SRakhmanova, ARazavi, HRazavi-Shearer, KReesink, H WRidruejo, ESafadi, RSagalova, OSanchez Avila, J FSanduijav, RSaraswat, VSchreter, IShah, S RShevaldin, AShibolet, OSilva, M OSokolov, SSonderup, MSouliotis, KSpearman, C WStaub, TStedman, CStrebkova, E AStruck, DSypsa, VTomasiewicz, KUndram, Lvan der Meer, A Jvan Santen, DVeldhuijzen, IVillamil, F GWillemse, SZuckerman, EZuure, F RPrabdial-Sing, NFlisiak, REstes, CengResearch Support, Non-U.S. Gov{\textquoteright}tEngland2015/01/07 06:00J Viral Hepat. 2015 Jan;22 Suppl 1:46-73. doi: 10.1111/jvh.12352.},
	month = {Jan},
	pages = {46-73},
	abstract = {The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries, and the relative impact of two scenarios was considered: (i) increased treatment efficacy while holding the treated population constant and (ii) increased treatment efficacy and increased annual treated population. Increasing levels of diagnosis and treatment, in combination with improved treatment efficacy, were critical for achieving substantial reductions in disease burden. In most countries, the annual treated population had to increase several fold to achieve the largest reductions in HCV-related morbidity and mortality. This suggests that increased capacity for screening and treatment will be critical in many countries. Birth cohort screening is a helpful tool for maximizing resources. In most of the studied countries, the majority of patients were born between 1945 and 1985.},
	keywords = {*Cost of Illness, *Mass Screening, *Models, Biological, Antiviral Agents/*therapeutic use, Disease Progression, Global Health, Hepatitis C, Chronic/diagnosis/*drug therapy/epidemiology, Humans, Prevalence, Treatment Outcome},
	isbn = {1365-2893 (Electronic)1352-0504 (Linking)},
	author = {Gane, E. and Kershenobich, D. and Seguin-Devaux, C. and Kristian, P. and Aho, I. and Dalgard, O. and Shestakova, I. and Nymadawa, P. and Blach, S. and Acharya, S. and Anand, A. C. and Andersson, M. I. and Arendt, V and Arkkila, P. and Baatarkhuu, O. and Barclay, K. and Ben-Ari, Z. and Bergin, C and Bessone, F. and Blokhina, N. and Brunton, C. R. and Choudhuri, G. and Chulanov, V. and Cisneros, L. and Croes, E. A. and Dahgwahdorj, Y. A. and Daruich, J. R. and Dashdorj, N. R. and Davaadorj, D. and de Knegt, R. J. and de Vree, M. and Gadano, A. C. and Gower, E. and Halota, W. and Hatzakis, A and Henderson, C. and Hoffmann, P. and Hornell, J. and Houlihan, D. and Hrusovsky, S. and Jarcuska, P. and Kostrzewska, K. and Leshno, M. and Lurie, Y. and Mahomed, A. and Mamonova, N. and Mendez-Sanchez, N. and Mossong, J. and Norris, S. and Nurmukhametova, E. and Oltman, M. and Oyunbileg, J. and Oyunsuren, Ts and Papatheodoridis, G. and Pimenov, N. and Prins, M. and Puri, P. and Radke, S. and Rakhmanova, A. and Razavi, H. and Razavi-Shearer, K. and Reesink, H. W. and Ridruejo, E. and Safadi, R. and Sagalova, O. and Sanchez Avila, J. F. and Sanduijav, R. and Saraswat, V. and Schreter, I. and Shah, S. R. and Shevaldin, A. and Shibolet, O. and Silva, M. O. and Sokolov, S. and Sonderup, M. and Souliotis, K. and Spearman, C. W. and Staub, T and Stedman, C. and Strebkova, E. A. and Struck, D and Sypsa, V and Tomasiewicz, K. and Undram, L. and van der Meer, A. J. and van Santen, D. and Veldhuijzen, I. and Villamil, F. G. and Willemse, S. and Zuckerman, E. and Zuure, F. R. and Prabdial-Sing, N. and Flisiak, R. and Estes, C.}
}
